[HTML][HTML] Rapid serological assays and SARS-CoV-2 real-time polymerase chain reaction assays for the detection of SARS-CoV-2: comparative study

…, V Cafagna, G De Palma, A Tufaro, VM Garrisi… - Journal of Medical …, 2020 - jmir.org
Background Real-time polymerase chain reaction (RT-PCR) testing for the identification of
viral nucleic acid is the current standard for the diagnosis of SARS-CoV-2 infection, but …

Assessment of nutritional and inflammatory status to determine the prevalence of malnutrition in patients undergoing surgery for colorectal carcinoma

…, I Abbate, A Casamassima, VM Garrisi… - Anticancer …, 2017 - ar.iiarjournals.org
Background/Aim: Colorectal Cancer is the fourth most frequent cause of cancer death
worldwide and its incidence increases from 50 years of age. It is often associated with protein-…

Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR

…, V Cafagna, G De Palma, A Tufaro, V Garrisi… - MedRxiv, 2020 - medrxiv.org
Background RT-PCR test for identification of viral nucleic acid is the current standard diagnostic
method for the diagnosis of COVID-19 disease but technical reasons limit the utilization …

[HTML][HTML] A strengthening the reporting of observational studies in epidemiology (STROBE): Are HE4 and CA 125 suitable to detect a Paget disease of the vulva?

…, P Casamassima, A Tufaro, G Cormio, VM Garrisi - Medicine, 2021 - journals.lww.com
Paget disease is a complex disorder that can be identified in the breast (mammary Paget
disease) or in other locations (extramammary Paget's disease) such as ano-genital skin (Paget …

Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization

…, V Mattioli, P Casamassima, A Paradiso, VM Garrisi… - Clinical …, 2014 - Elsevier
Background and aims Trans-hepatic arterial chemo-embolization is the most commonly
used treatment for unresectable hepatocellular carcinoma. The prognostic impact of tumor …

Body mass index and serum proteomic profile in breast cancer and healthy women: a prospective study

VM Garrisi, A Tufaro, P Trerotoli, I Bongarzone… - PLoS …, 2012 - journals.plos.org
Epidemiological studies suggest a possible association between BMI, diagnosis and clinical-pathological
breast cancer characteristics but biological bases for this relationship still …

Incidence and predictors of infections in patients with advanced non‐small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric …

…, F Pesola, A Belati, I Marech, V Garrisi… - Scandinavian …, 2023 - Wiley Online Library
Immune checkpoint inhibitors (ICIs) represent the cornerstone of the current treatment of non‐small
cell lung cancer (NSCLC). However, the occurrence of concomitant infections might …

Circulating hTERT DNA in early breast cancer

…, A Daniele, I Abbate, VM Garrisi… - Anticancer …, 2009 - ar.iiarjournals.org
Background: The objective of the study was to quantify the human telomerase reverse
transcriptase (hTERT) gene in the circulating DNA of patients with primary breast cancer (BC) and …

Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation

VM Garrisi, S Strippoli, S De Summa, R Pinto… - PloS one, 2014 - journals.plos.org
Introduction Selective inhibitors of BRAF, vemurafenib and dabrafenib are the standard of
care for metastatic melanoma patients with BRAF V600, while chemotherapy continued to be …

SELDI-TOF serum proteomics and breast cancer: which perspective?

VM Garrisi, I Abbate, M Quaranta… - Expert review of …, 2008 - Taylor & Francis
Despite the efforts of recent years, clinicians still lack reliable biomarkers for diagnosis,
prognosis and prediction of clinical outcomes in breast cancer patients. Owing to the large …